Spectrascience New Stock Probability of Future Stock Price Finishing Under 1.44
| SCIE Stock | USD 1.42 0.00 0.00% |
Spectrascience | Build AI portfolio with Spectrascience Stock |
Spectrascience New Target Price Odds to finish below 1.44
The tendency of Spectrascience Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.44 after 90 days |
| 1.42 | 90 days | 1.44 | about 84.43 |
Based on a normal probability distribution, the odds of Spectrascience New to stay under $ 1.44 after 90 days from now is about 84.43 (This Spectrascience New probability density function shows the probability of Spectrascience Stock to fall within a particular range of prices over 90 days) . Probability of Spectrascience New price to stay between its current price of $ 1.42 and $ 1.44 at the end of the 90-day period is near 1 .
Given the investment horizon of 90 days Spectrascience New has a beta of 0.52. This usually implies as returns on the market go up, Spectrascience New average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Spectrascience New will be expected to be much smaller as well. Additionally Spectrascience New has an alpha of 0.0167, implying that it can generate a 0.0167 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Spectrascience New Price Density |
| Price |
Predictive Modules for Spectrascience New
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Spectrascience New. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Spectrascience New Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Spectrascience New is not an exception. The market had few large corrections towards the Spectrascience New's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Spectrascience New, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Spectrascience New within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.02 | |
β | Beta against Dow Jones | 0.52 | |
σ | Overall volatility | 0.72 | |
Ir | Information ratio | -0.01 |
Spectrascience New Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Spectrascience New for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Spectrascience New can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Spectrascience New is not yet fully synchronised with the market data | |
| Spectrascience New is way too risky over 90 days horizon | |
| Spectrascience New may become a speculative penny stock | |
| Spectrascience New appears to be risky and price may revert if volatility continues | |
| Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
| Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (196.44 K). | |
| Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
| Spectrascience New has a frail financial position based on the latest SEC disclosures |
Spectrascience New Technical Analysis
Spectrascience New's future price can be derived by breaking down and analyzing its technical indicators over time. Spectrascience Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Spectrascience New. In general, you should focus on analyzing Spectrascience Stock price patterns and their correlations with different microeconomic environments and drivers.
Spectrascience New Predictive Forecast Models
Spectrascience New's time-series forecasting models is one of many Spectrascience New's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Spectrascience New's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Spectrascience New
Checking the ongoing alerts about Spectrascience New for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Spectrascience New help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Spectrascience New is not yet fully synchronised with the market data | |
| Spectrascience New is way too risky over 90 days horizon | |
| Spectrascience New may become a speculative penny stock | |
| Spectrascience New appears to be risky and price may revert if volatility continues | |
| Spectrascience New has high likelihood to experience some financial distress in the next 2 years | |
| Spectrascience New currently holds 6.38 M in liabilities. Spectrascience New has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Spectrascience New's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 5.15 K. Net Loss for the year was (4.47 M) with loss before overhead, payroll, taxes, and interest of (196.44 K). | |
| Spectrascience New currently holds about 27.88 K in cash with (1.51 M) of positive cash flow from operations. | |
| Spectrascience New has a frail financial position based on the latest SEC disclosures |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.